It is a chemicals private limited company based in Dehradun, Uttarakhand, India, established in 2022.
2022 | Dehradun, Uttarakhand, India | ActiveInvipro Pharmaceuticals Private Limited, a active private limited company, was established on 20 September 2022 in Dehradun, Uttarakhand, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290UR2022PTC014648. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Uma Shankar Sahni (Director), Sandeep Kishore (Director), Gosseya Hussain (Director). Past directors included Rani Bala, Sandeep Kishore, Gosseya Hussain. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 759, Iind Floor, Thdc Colony Dehrakhas, Dehradun, Uttarakhand, 248001.
U24290UR2022PTC014648
014648
20 September 2022
₹0.10 M
₹0.10 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Invipro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uma Shankar Sahni | Director | 20 Sep 2022 | Current |
| Sandeep Kishore | Director | 17 Jul 2024 | Current |
| Gosseya Hussain | Director | 13 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Invipro Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Invipro Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Invipro Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Invipro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invipro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Invipro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Gosseya Hussain was appointed as a Director was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Progress on Sandeep Kishore was appointed as a Director was appointed as a Director on 17 Jul 2024 & has been associated with this company since 1 year 5 months . was documented.
The activity Invipro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was completed.
The activity Uma Shankar Sahni was appointed as a Director was appointed as a Director on 20 Sep 2022 & has been associated with this company since 3 years 3 months . was completed.
Progress on Invipro Pharmaceuticals Private Limited was registered on 20 Sep 2022 with Roc Uttarakhand & aged 3 years 3 months as per MCA records. was documented.
The CIN of Invipro Pharmaceuticals Private Limited is U24290UR2022PTC014648.
Invipro Pharmaceuticals Private Limited is headquartered at H. No. 759, Iind Floor, Thdc Colony Dehrakhas, Dehradun, Uttarakhand, 248001.
Invipro Pharmaceuticals Private Limited was incorporated on 20 September 2022.
The current directors of Invipro Pharmaceuticals Private Limited are
The primary industry of Invipro Pharmaceuticals Private Limited is Chemicals.
Invipro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Invipro Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX